Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Yttrium 90 ibritumomab tiuxetan in lymphoma.
Cheung MC, Haynes AE, Stevens A, Meyer RM, Imrie K; Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. Cheung MC, et al. Among authors: imrie k. Leuk Lymphoma. 2006 Jun;47(6):967-77. doi: 10.1080/10428190600572582. Leuk Lymphoma. 2006. PMID: 16840185 Review.
Survival of patients with transformed lymphoma in the rituximab era.
Guirguis HR, Cheung MC, Piliotis E, Spaner D, Berinstein NL, Imrie K, Zhang L, Buckstein R. Guirguis HR, et al. Among authors: imrie k. Ann Hematol. 2014 Jun;93(6):1007-14. doi: 10.1007/s00277-013-1991-y. Epub 2014 Jan 11. Ann Hematol. 2014. PMID: 24414374
Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study.
Buckstein R, Fraser G, Cheung M, Kukreti V, Kuruvilla J, Imrie K, Piliotis E, Pond G, Windsor J, Ghorab Z, Shuoprasad K, Turner R, Meyer RM, Pritchard K, Walker S, Levine M, Crump M. Buckstein R, et al. Among authors: imrie k. Clin Lymphoma Myeloma Leuk. 2016 Jan;16(1):18-28.e4. doi: 10.1016/j.clml.2015.11.008. Epub 2015 Dec 1. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26711181 Free article. Clinical Trial.
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.
Reiman T, Savage KJ, Crump M, Cheung MC, MacDonald D, Buckstein R, Couban S, Piliotis E, Imrie K, Spaner D, Shivakumar S, Kuruvilla J, Villa D, Shepherd LE, Skamene T, Winch C, Chen BE, Hay AE. Reiman T, et al. Among authors: imrie k. Leuk Lymphoma. 2019 Apr;60(4):912-919. doi: 10.1080/10428194.2018.1515937. Epub 2018 Oct 10. Leuk Lymphoma. 2019. PMID: 30301414 Clinical Trial.
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.
Hicks LK, Woods A, Buckstein R, Mangel J, Pennell N, Zhang L, Imrie K, Spaner D, Cheung MC, Boudreau A, Reis M, Crump M, Berinstein NL. Hicks LK, et al. Among authors: imrie k. Bone Marrow Transplant. 2009 May;43(9):701-8. doi: 10.1038/bmt.2008.382. Epub 2008 Nov 24. Bone Marrow Transplant. 2009. PMID: 19029963 Clinical Trial.
Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction.
Pennell N, Woods A, Reis M, Buckstein R, Spaner D, Imrie K, Hewitt K, Boudreau A, Seth A, Berinstein NL. Pennell N, et al. Among authors: imrie k. J Mol Diagn. 2006 Feb;8(1):40-50. doi: 10.2353/jmoldx.2006.050050. J Mol Diagn. 2006. PMID: 16436633 Free PMC article.
Autologous stem cell transplant and combination immunotherapy of rituximab and interferon-α induces prolonged clinical and molecular remissions in patients with follicular lymphoma.
Smyth L, Buckstein R, Pennell N, Weerasinghe R, Cheung MC, Imrie K, Spaner D, Piliotis E, Chodirker L, Reis M, Ghorab Z, Zhang L, Boudreau V, Miliken A, Berinstein N. Smyth L, et al. Among authors: imrie k. Br J Haematol. 2019 Feb;184(3):469-472. doi: 10.1111/bjh.15118. Epub 2018 Jan 30. Br J Haematol. 2019. PMID: 29380359 Free article. No abstract available.
Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma.
Berinstein NL, Buckstein R, Imrie K, Spaner D, Mangel J, Tompkins K, Pennell N, Reis M, Pavlin P, Lima A, Couvadia A, Robinson J, Richardson P. Berinstein NL, et al. Among authors: imrie k. Bone Marrow Transplant. 2002 Feb;29 Suppl 1:S14-7. doi: 10.1038/sj.bmt.1703297. Bone Marrow Transplant. 2002. PMID: 11840156 Review.
94 results